SA4Ag, a 4-antigen Staphylococcus aureus vaccine, rapidly induces high levels of bacteria-killing antibodies
Highlights • A 4-antigen S. aureus vaccine (SA4Ag) targeting multiple virulence factors. • A Phase 1 study after finalizing manufacturing process prior to an efficacy study. • SA4Ag was well tolerated with a satisfactory safety profile in adults 18–
Gespeichert in:
Veröffentlicht in: | Vaccine 2017-02, Vol.35 (8), p.1132-1139 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Highlights • A 4-antigen S. aureus vaccine (SA4Ag) targeting multiple virulence factors. • A Phase 1 study after finalizing manufacturing process prior to an efficacy study. • SA4Ag was well tolerated with a satisfactory safety profile in adults 18– |
---|---|
ISSN: | 0264-410X 1873-2518 |
DOI: | 10.1016/j.vaccine.2017.01.024 |